2001

Schrauwen P, Saris WH, Hesselink MK: An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. Faseb J 15:2497-2502, 2001.

Schrauwen P, Hoppeler H, Billeter R, Bakker AH, Pendergast DR: Fiber type dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by high-fat diet. Int J Obes Relat Metab Disord 25:449-456, 2001.

Schrauwen P, Hesselink MK, Blaak EE, Borghouts LB, Schaart G, Saris WH, Keizer HA: Uncoupling protein 3 content is decreased in skeletal muscle of patientswith type 2 diabetes. Diabetes 50:2870-2873, 2001.

Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH: Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548-2554, 2001.

Koopman R, Schaart G, Hesselink MK: Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116:63-68, 2001.

Hesselink MK, Keizer HA, Borghouts LB, Schaart G, Kornips CF, Slieker LJ, Sloop KW, Saris WH, Schrauwen P: Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers. Faseb J 15:1071-1073, 2001.

Borghouts LB, Schrauwen P, Blaak EE, Wagenmakers AJ: Differences in acetate recovery factor between groups may interfere with tracer estimates of fact oxidation. J Appl Physiol 90:2520-2521, 2001.